Patient Monitoring Markets

Description

Patient monitoring is vital to care in operating rooms, emergency rooms, intensive care units and critical care units. It has proven invaluable for respiratory therapy, recovery rooms, outpatient care, transport, radiology, catheterization laboratories and gastroenterology departments, as well as for ambulatory, home and sleep screening applications. Patient monitoring can reduce the risk of infection and other complications, and it can assist in providing for patient comfort. Moreover, patient monitoring products measure, display and document physiological information obtained at regular intervals over time from sensors attached to the patient or other input devices. The qualifier “at regular intervals over time” is used to distinguish patient monitoring devices from diagnostic kits and devices, which are typically used once or a few times to diagnose a patient’s condition and/or plan a course of therapy. Measured parameters include electrocardiogram (ECG), invasive and noninvasive blood pressure, pulse rate, pulse oximetry, body temperature, respiration rate, end-tidal CO2 and other specialized parameters. Products vary from specialized single-parameter instruments to monitors with the ability to measure multiple parameters and interface with other instruments. This TriMark Publications report assesses the patient monitoring device market drivers and bottlenecks from the perspective of medical and manufacturer communities; discusses the potential benefits of the patient monitoring device market for various sectors of the medical community; establishes the current total market size and future growth of the patient monitoring device market and analyzes the current size and growth of various segments; provides current and forecasted market shares by the company; provides strategic recommendations for near-term business opportunities and assesses current commercial uses of the patient monitoring market.

TABLE OF CONTENTS

1. Introduction 11
1.1 Report Objectives 11
1.2 Scope of This Report 11
1.3 Methodology 12
1.4 Executive Summary 13

2. Top 30 Global Medical Device Companies, 2008 15
2.1 Johnson & Johnson 15
2.2 GE Healthcare 17
2.3 Siemens Healthcare 18
2.4 Medtronic 19
2.5 Cardinal Health 22
2.6 Baxter International 23
2.7 Philips Healthcare 24
2.8 Boston Scientific 25
2.9 Covidien 27
2.10 Becton Dickinson & Co. 28
2.11 Abbot Laboratories 30
2.12 Stryker 31
2.13 B. Braun 32
2.14 3M Healthcare 33
2.15 Zimmer Holdings 34
2.16 St. Jude Medical 35
2.17 Hospira 36
2.18 Smith & Nephew 36
2.19 Donaher 38
2.20 Synthes 38
2.21 Beckman Coulter 39
2.22 Olympus Medical Systems 40
2.23 Fresenius Medical Care 40
2.24 Alcon 41
2.25 Terumo Medical 42
2.26 C.R. Bard 43
2.27 Biomet 44
2.28 Dentsply International 45
2.29 Dräger Medical AG & Co. 46
2.30 Varian 47

3. Medical Design Excellence Awards (MDEA), 2008 49
3.1 MDEA Official Rules, 2009 49
3.2 MDEA Award Winners and Patient Monitoring Products, 2008 50
3.2.1 NetGuard Wireless Electrocardiograph System 50
3.2.2 Genesis DM Telehealth Device 50
3.2.3 E4D Dentist System 50
3.2.4 Tono-Pen Avia Applanation Tonometer 51
3.2.5 Healthy Living ThinLine Deluxe Flat Screen Blood Pressure Monitor, Model BSD-3007 51
3.2.6 Acuson P10 Handheld Diagnostic Ultrasound Unit 51
3.2.7 MicroDose Mammography System 52
3.2.8 Nuance Full-field Digital Mammography Unit 52
3.2.9 xCAT Computed Tomography Scanner 52
3.2.10 XDS Extravasation Detector 53
3.3 MDEA Award Winners and Patient Monitoring Products, 2007 and 2006 53
3.3.1 Mobile Clinical Assistant 53
3.3.2 Halo 360 Esophageal Tissue Ablation System 53
3.3.3 OmniPod Insulin Management System 54
3.3.4 Rad-57 Portable Pulse CO-Oximeter 54

4. Global Medical Device Market Outperforms Drug Market Growth 55
4.1 Market Shares of Medical Devices 56

5. Patient Monitors 57
5.1 Patient Monitoring Markets 58
5.2 Competition from Asian Manufacturers 60
5.3 Opportunities for Midrange Monitors 60
5.4 Size of Patient Monitoring Market 62
5.5 Drivers and Restraints of Patient Marketing 62
5.6 Global Market for Patient Monitoring Systems 63
5.7 Industry Trends 64
5.8 Price Pressures 64
5.9 Ease of Use of Patient Monitors 65
5.10 Reducing Medical Errors 65
5.11 Clinical Solutions 65
5.12 Data Interfaces and Interoperability 66
5.13 Aggressive Marketing Strategies and End-User Benefits to Spur Growth 67
5.14 Newer Markets, Higher Replacement Rates Provide Impetus 68
5.15 Stringent Regulations to Offset Inconsistent Reimbursement Policies 68
5.16 Advanced Systems Initiate Market Expansion and Combat Staff Shortages 68
5.17 Aging Population Provides Sustained Need for Equipment While Specialty and Alternate Care Centers Offer New Markets 68
5.18 Wireless Data Transfer 69
5.19 Integration of Data/Information with Patient Monitors Gaining Priority 69
5.20 Hospital Opportunities 69
5.21 Supplier Consolidation 69

6. Multiparameter Patient Monitors 71
6.1. Multiparameter Patient Monitoring Systems 71
6.1.1 Future of Multiparameter Patient Monitoring Systems 73
6.1.2 Multiparameter Patient Monitors—Product Introduction 73
6.1.3 Product Trends and Technologies—Multiparameter Patient Monitors 74
6.1.4 Advanced Monitoring Parameters in Multiparameter Patient Monitors 74
6.1.5 Anesthetic Assessment Using Multiparameter Brain Monitors 74
6.2 Leading Players in Multiparameter Patient Monitoring Manufacture 75
6.2.1 Analogic Corporation—Company Overview 76
6.2.2 Product Offering 76
6.2.3 Smiths Medical—Company Overview 78
6.2.3.1 Product Offering 78
6.2.4 CAS Medical Systems, Inc.—Company Overview 82
6.2.4.1 Product Offering 83
6.2.5 Omron Corporation—Company Overview 84
6.2.5.1 Product Offering 85
6.2.6 Opto Circuits (India) Ltd.—Company Overview 88
6.2.6.1 Opto Circuits Subsidiaries 89
6.2.6.2 Product Offering 90
6.2.7 Dräger Medical—Company Overview 91
6.2.7.1 Product Offering 91
6.2.8 Fukuda Denshi Group—Company Overview 100
6.2.8.1 Product Offering 101
6.2.9 GE Healthcare—Company Overview 103
6.2.9.1 Product Offering 103
6.2.10 Masimo—Company Overview 107
6.2.10.1 Product Offering 107
6.2.11 Mindray—Company Overview 109
6.2.11.1 Product Offering 109
6.2.12 Nihon Kohden—Company Overview 114
6.2.12.1 Product Offering 115
6.2.13 Philips Healthcare—Company Overview 121
6.2.13.1 Product Offering 123
6.2.14 Schiller A.G.—Company Overview 126
6.2.14.1 Product Offering 126
6.2.15 Siemens—Company Overview 127
6.2.15.1 Product Offering 128
6.2.16 Spacelabs Healthcare—Company Overview 130
6.2.16.1 Product Offering 131
6.2.17 Welch Allyn—Company Overview 136
6.2.17.1 Product Offering 136

7. Pulse Oximetry 140
7.1 Principles of Pulse Oximetry Technology 141
7.2 Clinical Use 142
7.3 Limitations of Conventional Pulse Oximetry 143
7.4 Pulse Oximetry Market Drivers and Restraints 144
7.5 Market Opportunities 144
7.5.1 Expansion to Non-Critical Care Settings 144
7.5.2 Carboxyhemoglobin Detection 144
7.5.3 Methemoglobin Detection 145
7.5.4 Plethysmograph Variability Index (PVI) 145
7.5.5 Total Hemoglobin (SpHb) 145
7.5.6 Signal Processing and Innovative Sensor Technology 146
7.5.7 Cerebral Oximetry 146
7.6 Global Market for Pulse Oximeters 147
7.6.1 Dominant Players in Pulse Oximeter Market 148
7.6.2 Benefits of Products and Technology 149
7.6.3 Business Strategies for the Pulse Oximetry Market 149
7.7 Pulse Oximetry Products 150
7.7.1 Circuit Boards 150
7.7.2 Sensors 151
7.7.3 Remote-Alarm and Monitoring Solutions 151
7.8 Product Offering—Pulse Oximeters/Monitors 152
7.9 Drivers and Restraints of Oximeter Markets 156
7.10 Demand for Pulse Oximeters in Hospitals and Alternate Care Market Generates Growth 156

8. Electrocardiogram Services 157
8.1 Market 157
8.2 Competition 158
8.3 Opportunites and Challenges 158
8.4 Cardiac Monitoring Products 159
8.4.1 Resting ECG Systems 159
8.4.2 Cardiac Stress Testing Systems 160
8.4.3 Holter Monitoring Systems 160
8.4.4 Cardiac Rehabilitation Telemetry Systems 161
8.4.5 Cardiology Data Management Systems 161
8.4.6 Advantages of Cardiac Monitoring Products 162
8.4.7 Product Suppliers 163
8.4.7.1 Monebo 163
8.4.7.2 CompuMed, Inc. 163
8.4.7.3 Cardiac Science Corp. 164
8.4.7.4 Royal Philips Electronics 164
8.4.7.5 Datascope (Mindray) 164
8.4.7.6 Fakuda Denshi 165
8.4.7.7 Scott Care 165
8.4.7.8 Dräger 165

9. Capnography 166
9.1 Use in Hospitals 167
9.2 Capnography Market Size 168
9.3 Commercially-Available Devices 168

10. Maternal Fetal Monitors 170

11. Blood Pressure Monitors 175
11.1 Market Overview 175
11.2 Market Sectors 175
11.3 Blood Pressure Monitoring Products 177
11.3.1 Non-Invasive Blood Pressure Cuffs 177
11.3.2 Invasive Arterial Catheters 180

12. Anesthesia Monitoring 182
12.1 Anesthesia Monitoring Market Size 182
12.2 Anesthesia Monitoring Competition 182
12.3 Anesthesia Monitoring Products 182
12.3.1 Neurological Monitors 182
12.4 Market Size 184
12.5 Neurological Intraoperative Monitoring 185
12.5.1 Neurological Monitoring in Intensive Care 186

13. Trends in Mobile Medical Monitor Device Design and Manufacturing 188
13.1 Pervasive Patient Monitoring 189

14. Home Healthcare 190
14.1 Home Healthcare Market 191
14.2 U.S. Home Healthcare Scenario 192
14.3 Homecare Providers 192
14.4 Medicare Certified Agencies 192
14.5 Medicare-Certified Hospices 193
14.6 Non-Medicare-Certified Agencies 193
14.7 Home Care Expenditures and Utilization 193
14.8 Medicare Home Health 194
14.9 Managed Care 195
14.10 Homecare Recipients 195
14.11 Caregivers 196
14.12 Formal Caregivers 196
14.13 Future of Home Healthcare in the U.S. 197
14.14 Selected List of Home Healthcare Products 198
14.15 Leading U.S. Home Healthcare Providers 203
14.16 Company Overview of Two of the 50 Home Healthcare Providers 205

15. Telemedicine and Telehealth 207
15.1 What Are Telemedicine and Telehealth? 207
15.2 Why Telemedicine? 207
15.3 Defining Telemedicine 207
15.4 Types of Telemedicine Services 208
15.5 Delivery Mechanisms 208
15.6 The U.S. Telehealth Survey 209
15.7 Telemonitoring 209
15.8 Market Trends—Telemonitoring 210
15.9 Telehealthcare in Europe 210
15.9.1 Scottish Center for Telehealth 211
15.10 Telehealth and Telehomecare Bound to Get Big in Japan 211
15.11 MedStar System 212
15.12 MedApps D-PAL Remote Patient Monitoring System for Diabetes 213
15.13 Telehealth and Troubled Pregnancies 213
15.14 Tele-Cardiology in the Forefront of New Telehealth Services 214
15.15 Economical Benefits of Tele-Cardiology 214
15.16 ECG Telemetry Devices Market 215
15.17 Remote Patient Monitoring In-Home Devices from Philips 216
15.18 Glucose Monitoring Made Easy by Gluco Tel System 217
15.19 Aerotel Medical Systems, Ltd.—Company Overview 218
15.19.1 Heartline ECG Monitoring 218
15.20 Home Telehealth, Ltd. U.K 223

16. U.S. Market for Medical Devices 225
16.1 U.S. Export of Medical Devices to Japan 225
16.2 U.S. Exports and Imports of Medical Devices 226
16.3 Facts and Figures of U.S Medical Device Market 227
16.4 U.S. Patient Monitoring Market 227
16.5 Trends Affecting the U.S. Patient Monitoring Equipment Industry 228
16.6 U.S. Market Drivers 228
16.7 Aging Patient Population 228
16.8 Hunger and Obesity 229
16.9 Nursing Shortage 230
16.10 Shifts from Hospital to Outpatient Care 230
16.11 U.S. Market Restraints 230
16.12 Government Reguation of Medical Devices 232
16.12.1 FDA’s Premarket Clearance and Approval Requirements 232
16.12.2 510(k) Clearance Process 232
16.12.3 Premarket Approval Process 233
16.12.4 Clinical Trials 233
16.12.5 Continuing FDA Patient Monitoring Product Regulation 233
16.12.6 International Regulations 234

17. European Patient Monitoring Market 235
17.1 E.U. Production of Medical Devices 236
17.2 E.U. Medical Device Consumption 237
17.3 E.U. Exports and Imports 237
17.4 Main Medical Device Markets in Europe 238
17.4.1 France 238
17.4.2 United Kingdom 238
17.4.3 Spain 238
17.4.4 Germany 238
17.4.5 Italy 239
17.4.6 Switzerland 239
17.4.7 Netherlands 239
17.4.8 Sweden 239
17.4.9 Czech Republic 239
17.4.10 Greece 239
17.5 Medical Device Industry in Turkey 240
17.5.1 Turkey—Exports 240
17.6 European Trends and Drivers 241

18. Asia/Pacific Patient Monitoring Market 242
18.1 China 242
18.1.1 Facts and Figures of Chinese Medical Device Market 242
18.2 Japan 243
18.2.1 Japan’s Aging Population and the Demand for Foreign Medical Devices 243
18.2.2 Japanese Medical Device Market 244
18.3 India 245
18.3.1 India—Imported Medical Devices 246
18.3.2 Global Medical Toolmakers Throng India 247
18.4 Indian Healthcare 2008 at a Glance and the Opportunities for Foreign Investments 247
18.4.1 Indian Healthcare, a $34.2 Billion Market 247
18.4.2 Indian Healthcare Market—Growth Perspective 247
18.4.3 Medical Infrastructure—Current State 248
18.4.4 Medical Education and Manpower—India’s Advantage 248
18.4.5 Budget 2007–2008 and Indian Healthcare Perspective 249
18.4.6 Healthcare Budget 2007–2008 Highlights 249
18.4.7 Key Trends and Drivers—Shift to Lifestyle Related Diseases 249
18.4.8 Growing Middle Class and Patient Preferences 250
18.4.9 JCI Accreditated Organizations in India 250
18.4.10 Healthcare Cities—The Evolving Concept of Healthcare in India 250
18.4.11 Healthcare Insurance—Current and Future Scenario 251
18.4.12 Impelling Technology 252
18.4.13 Reverse in Brain Drain 252
18.4.14 Funding by Private Equity 252
18.4.15 Select Players in India—Apollo Hospitals Enterprise, Ltd. 253
18.4.16 Fortis Healthcare 253
18.4.17 Wockhardt Hospitals 253
18.4.18 Manipal Health Systems 253
18.4.19 Narayana Hrudayalaya 254
18.4.20 Max Healthcare 254
18.4.21 Columbia Asia 254
18.4.22 Global Hospitals 254
18.4.23 Artemis Health Institute 254
18.4.24 New Entrants—Naresh Trehan’s MediCity 254
18.4.25 Aditya Birla Memorial Hospital 254
18.4.26 Reliance ADAG Healthcare 255
18.4.27 Foreign Players 255
18.4.28 Opportunities in Medical Value Travel 255
18.4.29 Medical Equipment Manufacturing and Leasing in India 255
18.4.30 Healthcare Outsourcing 256
18.5 Korea 256
18.6 Singapore 257
18.6.1 Singapore—Market Review 257
18.6.2 Singapore—Import Market 257
18.7 Malaysia 257
18.7.1 Malaysia Serving the Asia and World Healthcare Market 259
18.8 Patient Monitoring Market Presents Opportunities in South Africa 260
18.9 Vietnam 260
18.9.1 Vietnam—Market Overview 260
18.9.2 Vietnam—Market Profile 260
18.9.3 Vietnam—Import Market 260
18.9.4 Vietnam—Domestic Production 261
18.9.5 Vietnam—Third Country Imports 261
18.9.6 Vietnam—Market Position in the U.S. 261
18.10 Russia 262
18.11 Australia 262
18.12 Rest of World Patient Monitoring Market 262
18.13 Argentina Medical Device Market 262
18.13.1 Argentina—Medical Instruments and Accessories Market 263

Appendix 1: Conditions Affecting U.S. Trade in Medical Devices 265
Appendix 2: Healthcare in the U.S. 270
Appendix 3: Business Developments in Patient Monitoring Sector 278
Appendix 4: U.S. Medicare—A Snapshot 282
Appendix 5: U.S. Medicaid at a Glance 293
Appendix 6: Alternate Financial Solution for Medical Technology Acquisition 296
Appendix 7: Registering Medical Products in China 300
Appendix 8: Registering Medical Products in India 302
Appendix 9: Registering Medical Products in Japan 304
Appendix 10: Registering Medical Products in Russia 306
Appendix 11: Registering Medical Products in Mexico 308
Appendix 12: Group Purchasing Organizations 312
Appendix 13: Company Directory 313
Appendix 14: Abbreviations 317


INDEX OF TABLES

Table 2.1: Johnson & Johnson Snapshot, 2007–2008 15
Table 2.2: GE Healthcare Snapshot, 2007–2008 17
Table 2.3: Siemens Healthcare Snapshot, 2007–2008 18
Table 2.4: Medtronic Snapshot, 2007–2008 19
Table 2.5: Cardinal Health Snapshot, 2007–2008 22
Table 2.6: Baxter International Snapshot, 2007–2008 23
Table 2.7: Philips Healthcare Snapshot, 2007–2008 24
Table 2.8: Boston Scientific Snapshot, 2007–2008 25
Table 2.9: Boston Scientific Sales by Product Category, 2003-2007 25
Table 2.10: Covidien Snapshot, 2007–2008 27
Table 2.11: Becton Dickinson & Co. Snapshot, 2007–2008 28
Table 2.12: Abbot Laboratories Snapshot, 2007–2008 30
Table 2.13: Stryker Snapshot, 2007–2008 31
Table 2.14: B. Braun Snapshot, 2007–2008 32
Table 2.15: 3M Healthcare Snapshot, 2007–2008 33
Table 2.16: Zimmer Holdings Snapshot, 2007–2008 34
Table 2.17: St. Jude Medical Snapshot, 2007–2008 35
Table 2.18: Hospira Snapshot, 2007–2008 36
Table 2.19: Smith & Nephew Snapshot, 2007–2008 36
Table 2.20: Donaher Snapshot, 2007–2008 38
Table 2.21: Synthes Snapshot, 2007–2008 38
Table 2.22: Beckman Coulter Snapshot, 2007–2008 39
Table 2.23: Olympus Medical System Snapshot, 2007–2008 40
Table 2.24: Fresenius Medical Care Snapshot, 2007–2008 40
Table 2.25: Alcon Snapshot, 2007–2008 41
Table 2.26: Terumo Medical Snapshot, 2007–2008 42
Table 2.27: C.R. Bard Snapshot, 2007–2008 43
Table 2.28: Biomet Snapshot, 2007–2008 44
Table 2.29: Dentsply International Snapshot, 2007–2008 45
Table 2.30: Dräger Medical Snapshot, 2007–2008 46
Table 2.31: Varian Snapshot, 2007–2008 47
Table 4.1: Leading Medical Device Companies, 2007 55
Table 4.2: Top 30 Companies of Medical Devices and Their Sales, 2007 56
Table 5.1: Overall Global Patient Monitoring Sales and Projections, 2006–2013 57
Table 5.2: U.S. Patient Monitoring Market and Projections, 2006–2013 57
Table 5.3: U.S. Patient Monitoring Home Care Market and Projections, 2006–2013 57
Table 5.4: U.S. Patient Monitoring Handheld and Wearable Market and Projections, 2006–2013 58
Table 5.5: Technology Synopsis for Each Market Segment in the U.S. 58
Table 5.6: Estimated Market Share Analysis for Top Suppliers—U.S. Patient Monitoring Market Segments 59
Table 5.7: Average Equipment Selling Price for Each Market Segment in the U.S. 59
Table 5.8: Commonly-Monitored Parameters in the U.S. 59
Table 5.9: Summary of Market Projections 62
Table 5.10: Drivers of Patient Monitoring Markets 62
Table 5.11: Restraints of Patient Monitoring Markets 63
Table 5.12: Recent Sector M&A Activity 70
Table 5.13: Mergers and Acquisitions, 1997–2008 70
Table 6.1: Websites for Other Manufacturers 75
Table 6.2: Nihon Kohden Sales by Product Category 121
Table 7.1: Growth Drivers in the U.S. Pulse Oximetry Sensor Market 144
Table 7.2: Pulse Oximetry Monitoring Equipment Market: Major Market Participants 149
Table 7.3: Pulse Oximetry Components and Markets for Distribution 150
Table 7.4: Popular Brands of Oximeters 155
Table 7.5: Principal Competitive Factors for Pulse Oximetry Products 155
Table 7.6: Drivers of Pulse Oximetry Markets 156
Table 7.7: Restraints of Pulse Oximetry Markets 156
Table 8.1: Worldwide Cardiac Equipment Monitoring Market: Revenue and Forecasts, 2005–2013 157
Table 8.2: U.S. Cardiac Equipment Monitoring Market: Revenue and Forecasts, 2005–2013 158
Table 8.3: Challenges in Cardiac Monitoring 158
Table 8.4: Leading Competitors for Cardiac Moniitoring Systems 163
Table 9.1: U.S. Capnography Monitoring Equipment Market, 2006-2013 168
Table 10.1: Key Companies in Fetal Monitors 170
Table 10.2: Specific Categories of Fetal Monitors 171
Table 10.3: Available Equipment for Fetal Monitoring 171
Table 10.4: Recent Fetal Monitor Sector M&A Activity 171
Table 11.1: Key Companies in Blood Pressure Monitors 176
Table 11.2: Available Equipment for Blood Pressure Monitoring 176
Table 11.3: Recent Blood Pressure Sector M&A Activity 177
Table 12.1: U.S. Anesthesia Monitoring Equipment Market, 2006-2013 182
Table 12.2: Worldwide Neurological Equipment Monitoring Market: Revenue and Forecasts, 2005–2013 185
Table 12.3: U.S. Neurological Equipment Monitoring Market: Revenue and Forecasts, 2005–2013 185
Table 14.1: Number of Medicare-Certified Home Care Agencies, 1967–2007 192
Table 14.2: U.S. Number of Home Healthcare Workers and Medicare-Certified Agencies, 2007 196
Table 14.3: Comparison of Hospital, SNF and Home Health Medicare Charges, 2005–2007 197
Table 14.4: U.S. Annual Expenditure on Home Healthcare Products, 2006 197
Table 14.5: U.S. Medicaid Spending on Home Healthcare and Personal Care, 2006 203
Table 15.1: Telehealth Benefits 209
Table 15.2: Telemonitoring Market Highlights 210
Table 15.3: Benefits of HeartView Tele-Cardiology Service 214
Table 15.4: Drivers for Remote Patient Monitoring 215
Table 15.5: Barriers to Remote Patient Monitoring 215
Table 15.6: Forecast for U.S. Remote Patient Monitoring Devices, 2003–2010 216
Table 15.7: Leading Market Participants in Telemetry Devices 216
Table 16.1: Japanese Medical Devices Market Size, 2005–2007 226
Table 16.2: U.S. Market for Medical Devices, 2002–2007 227
Table 16.3: Senior Citizen Use of Medical Services in the U.S. 229
Table 16.4: Impact of Aging Population on Patient Monitoring Demand in the U.S. 229
Table 16.5: Nursing Staffing Levels Contribute to Incidents 230
Table 16.6: The U.S. Medical Equipment Market Value, 2004-2007 231
Table 16.7: Top U.S. Export Markets of Medical Devices, 2006 231
Table 17.1: Turkish Medical Devices Export, 2002–2007 241
Table 17.2: Turkish Medical Devices Export by Product Groups, 2003-2007 241
Table 18.1: Japanese Medical Device Market, 2005-2007 243
Table 18.2: Percentage of Elderly Population in Developed Countries, 1950, 1985, 2000 and 2020 243
Table 18.3: Presence of Foreign Companies in Japanese Market 244
Table 18.4: Leading Manufacturers of Medical Devices in Japan 245
Table 18.5: Upcoming Healthcare Cities 251
Table 18.6: Foreign Companies Entering India 256
Table 18.7: Foreign Companies with a Presence in Malaysia 259
Table 18.8: Global Medical Equipment Market, 2008–2011 259
Table 18.9: Summary of Medical Device Market in Malaysia, 2008 259
Table 18.10: Argentina—Medical Device Industry Market Size, 2004-2006 263
Table 18.11: Argentina—Medical Instruments and Accessories Market, 2005-2007 264
Table App. 1.1: Summary of the U.S., E.U. and Japanese Medical Device Markets 267
Table App. 2.1: Health Expenditures for Selected Type of Services, 2000, 2005, 2010 and 2015 272
Table App. 2.2: U.S. Healthcare Industry Overview 273
Table App. 2.3: U.S. Population without Health Insurance, 2007 274
Table App. 3.1: Important Business Developments in the Patient Monitoring Sector 278
Table App. 4.1: General Medicare—Statistics 292
Table App. 6.1: Financial Services Offered by Medical Devices and Diagnostics Companies 299
Table App. 12.1: Top Ten GPOs by Number of Hospital Members (Psychiatric and Rehabilitation Hospitals Included) by Total Number of Hospital Members 312


INDEX OF FIGURES

Figure 2.1: Johnson & Johnson Sales by Segment, 2007 16
Figure 2.2: GE Healthcare Profit, 2006 17
Figure 2.3: Siemens Healthcare Revenue Trend 18
Figure 2.4: Medtronic Revenue by Segment, 2007 19
Figure 2.5: Medtronic Revenue by Geography, 2007 20
Figure 2.6: Medtronic Revenue and Operating Income, 2005–2007 20
Figure 2.7: Medtronic Market Share, 2007 21
Figure 2.8: Baxter International Revenue by Segment, 2006–2007 23
Figure 2.9: Boston Scientific Investment in Research and Development, 2007 26
Figure 2.10: Boston Scientific Sales by Geographic Segment, 2007 26
Figure 2.11: Covidien FY 2005–2007 27
Figure 2.12: Becton Dickinson Revenue by Segment, 2007 28
Figure 2.13: Becton Dickinson Revenue and Operating Income, 2005–2007 29
Figure 2.14: Becton Dickinson Revenue by Geography, 2007 29
Figure 2.15: Abbot Laboratories Medical Devices Sales, 2007 30
Figure 2.16: Abbot Sales by Business Group, 2007 31
Figure 2.17: Abbot Sales by Geography, 2007 31
Figure 2.18: Zimmer Revenue by Geography, 2006 34
Figure 2.19: St. Jude Medical Revenue by Segment 35
Figure 2.20: C.R. Bard Revenue by Segment, 2006–2007 43
Figure 2.21: Biomet Sales, 2006–2007 45
Figure 2.22: Dentsply International Revenue by Segment, 2004–2006 46
Figure 2.23: Varian Revenue and Net Income, 2003-2007 47
Figure 5.1: Worldwide Market Segmentation—High-, Mid- and Low-End Products 60
Figure 5.2: Total Worldwide Patient Monitoring Market by Segment 61
Figure 5.3: Worldwide Markets for Patient Monitors, Clinical Measurements, Clinical Information Systems and Networking 61
Figure 5.4: Only 28% of U.S. Primary Care Doctors Use Electronic Medical Patient Records, 2006 67
Figure 6.1: Block Diagram of a Multiparameter Patient Monitor 72
Figure 6.2: Smiths Group Market Analysis by Destination 82
Figure 6.3: Philips Is the World Leader in Patient Monitoring Market, 2000–2007 122
Figure 7.1: Light Absorption by Pulse Oximeters in the Finger 141
Figure 7.2: Block Diagram—Pulse Oximeter 141
Figure 7.3: U.S. Pulse Oximetry Market Share by Company 148
Figure 14.1: Global Home Healthcare Market, 2007 ($140 Billion plus) 191
Figure 14.2: U.S. Personal Healthcare Expenditures, 2006 193
Figure 14.3: U.S. Sources of Payment for Home Health, 2006 194
Figure 14.4: U.S. Percent Medicare Payments by Benefit, 2000–2007 195
Figure 14.5: U.S. Home Healthcare Services, Total Employment, 1996–2007 196
Figure 15.1: The MedStar System 212
Figure 16.1: U.S. Export of Medical Devices to Japan, 2007 225
Figure 17.1: Health Spending on Medical Technology, 2007 235
Figure 17.2: European Medical Technology Market by Country 235
Figure 17.3: Projected Composition of E.U.’s Population by Age 237
Figure 18.1: Composition of Japan’s Population by Age, 1950-2050 243
Figure 18.2: Growth Forecast for Medical Device Market in India 246
Figure 18.3: Segmentation of Indian Medical Device Market 247
Figure 18.4: Indian Healthcare Market Size 248
Figure 18.5: Indian Healthcare Infrastructure 248
Figure 18.6: Hospitalization Cases, 2007 250
Figure 18.7: Insured Patients as a Percentage of Total Patients 251
Figure 18.8: Health Insurance Revenue as a Percentage of Total Healthcare Revenue 252
Figure 18.9: Medical Equipments—Market Distribution 255
Figure 18.10: Outsourcing Scenario 2003–2004 and 2007–2008 256
Figure 18.11: Argentina—Laboratory Analytical Instruments Market Share, 2006 263
Figure 18.12: Argentina—Medical Instruments and Accessories Market, 2006 264
Figure App. 1.1: Global Production in the Medical Device Industry, 2005 268
Figure App. 1.2: Consumption of Medical Devices, 2005 268
Figure App. 1.3: Global Trade in Medical Devices by Major Traders, 2005 268
Figure App. 1.4: Share of the U.S. Shipments by Major Segments, 2005 269
Figure App. 1.5: Bioengineering Grant Awards from National Institutes for Health (NIH) for Various Diseases 269
Figure App. 2.1: Dimensions of a High Performance Health System 270
Figure App. 2.2: Total Spending on Healthcare in the U.S., 1960–2007 271
Figure App. 2.3: International Per Capita Healthcare Spending by Country, 2006 272
Figure App. 2.4: Number Uninsured and Uninsured Rate in the U.S., 1987–2006 274
Figure App. 2.5: Obese Adults in the U.S., 2006 275
Figure App. 2.6: Prevalence of Obesity by Age, Race and Sex, U.S., 2006 275
Figure App. 2.7: Age Adjusted Prevalence of Hypertension in U.S. Men and Women, 2006 276
Figure App. 2.8: Age Adjusted Prevalence of Hypertension in the U.S., 2006 276
Figure App. 4.1: Total U.S. Medicare Population, 2005 282
Figure App. 4.2: Medicare Pays Nearly Half of the Beneficiaries 283
Figure App. 4.3: Net Federal Cost of Medicare Prescription Drug Benefit 290
Figure App. 5.1: Medicaid in the Health System, 2005 293
Figure App. 5.2: Medical Expenditure by Service, 2005 294
Figure App. 5.3: Medicaid Enrollees and Expenditures by Enrollment Group, 2003 295
Figure App. 6.1: Factors to Be Taken into Consideration before Deciding on an Option 297
Figure App. 11.1: Brazilian Commercial Balance, 1950–2005 308